Center-Authored Papers

Filters: Author is Jakubowiak, Andrzej J  [Clear All Filters]
Journal Article
Stewart KA, Rajkumar VS, Dimopoulos MA, Masszi T, Špička I, Oriol A, Hájek R, Rosiñol L, Siegel DS, Mihaylov GG et al..  2015.  Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.. The New England journal of medicine. 372(2):142-52. Abstract
Jakubowiak AJ, Benson DM, Bensinger WI, Siegel DSD, Zimmerman TM, Mohrbacher A, Richardson PG, Afar DEH, Singhal AK, Anderson KC.  2012.  Phase I Trial of Anti-CS1 Monoclonal Antibody Elotuzumab in Combination With Bortezomib in the Treatment of Relapsed/Refractory Multiple Myeloma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(16):1965. Abstract
Hussein MA, Bolejack V, Zonder JA, Durie BGM, Jakubowiak AJ, Crowley J, Barlogie B.  2009.  Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(21):3510-7. Abstract